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SHORT COMMUNICATION
Association of the AFF3 gene and IL2/IL21 gene region
with juvenile idiopathic arthritis
A Hinks1, S Eyre1, X Ke1, A Barton1, P Martin1, E Flynn1, J Packham2, J Worthington1, Childhood
Arthritis Prospective Study (CAPS), UKRAG Consortium, BSPAR Study Group3 and W Thomson1
1arc-EU, Stopford Building, The University of Manchester, Manchester, UK and 2Haywood Hospital, University Hospital of North
Staffordshire, Stoke on Trent, Staffordshire, UK
Recent genetic studies have led to identification of numerous loci that are associated with susceptibility to autoimmune
diseases. The strategy of using information from these studies has facilitated the identification of novel juvenile idiopathic
arthritis (JIA) susceptibility loci, specifically, PTPN22 and IL2RA. Several novel autoimmune susceptibility loci have recently
been identified, and we hypothesise that single-nucleotide polymorphisms (SNPs) within these genes may also be JIA
susceptibility loci. Five SNPs within the genes AFF3, IL2/IL21, IL7R, CTLA4 and CD226, previously associated with multiple
autoimmune diseases were genotyped, in a large data set of Caucasian JIA patients and controls, and tested for association
with JIA. We identified two susceptibility loci for JIA, AFF3 and the IL2/IL21 region and additional weak evidence supporting an
association with the CTLA4 and IL7R genes, which warrant further investigation. All results require validation in independent
JIA data sets. Further characterisation of the specific causal variants will be required before functional studies can
be performed.
Genes and Immunity (2010) 11, 194–198; doi:10.1038/gene.2009.105; published online 14 January 2010
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Introduction
Autoimmune diseases are caused by dysregulation of the
immune system leading to an immune response to self-
tissue. Autoimmune diseases are complex genetic dis-
eases and in the last few years great progress has been
made in the search for susceptibility loci.1,2 As more
confirmed autoimmune disease susceptibility loci are
identified, an interesting story is emerging in that many
of these loci predispose to more than one autoimmune
disease. This confirms the hypothesis that shared alleles
contribute to a spectrum of diseases and suggests that
common immunological pathways are involved in
susceptibility to these phenotypically distinct diseases.3
Juvenile idiopathic arthritis (JIA) is another complex
genetic autoimmune disease characterised by chronic
inflammatory disease in children. It is a group of
heterogeneous disorders but encompasses all forms of
arthritis of unknown aetiology that starts before the age
of 16 and which persists for at least 6 weeks.4 The
strategy of using information from autoimmune disease
genome-wide association studies or candidate gene
studies have facilitated the search for novel JIA suscept-
ibility loci. Indeed two recently identified confirmed JIA
susceptibility loci, PTPN225 and IL2RA6 are putative
autoimmune susceptibility genes as they also show
association with rheumatoid arthritis (RA),5,7 type I
diabetes (T1D)7,8 and Graves’ disease.9,10 In addition,
using a strategy of examining confirmed RA suscept-
ibility loci in JIA, we have recently reported evidence for
association of two further loci (TRAF1/C5 and STAT4)
with JIA susceptibility.11
Several novel putative autoimmune susceptibility loci
have recently been identified with association with
multiple autoimmune diseases. These include the IL2/21
region on chromosome 4q2312,13 and the genes encoding
IL7R,14–16 CTLA4,17 AFF314 and CD226.18 We hypothesise
that these genes may also confer susceptibility to JIA
and, therefore, the aim of this study was to determine
whether single-nucleotide polymorphisms (SNPs) within
these genes are also associated with susceptibility to JIA.
Results and discussion
In this study, using a strategy of examining previously
associated autoimmune loci in JIA, we have identified
association of two loci with JIA susceptibility (Table 1).
First, we show association of a SNP (rs1160542) in the 50
region of the AFF3 gene (Table 1), a gene that is
preferentially expressed in lymphoid cells and has a
potential regulatory role in lymphoid development.19
This SNP has been associated with RA20 and a perfect
proxy SNP (r2¼ 1), rs9653442 has been associated with
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T1D14 with similar odds ratio and allele frequencies to
that observed in this study of JIA.
Second, we found strong association of a SNP
(rs6822844) mapping within the IL2–IL21 locus on
chromosome 4q27, which has previously been associated
with RA, T1D and coeliac disease (Table 1).12,13 The SNP
lies approximately 24 kb 50 of the IL21 gene. The SNP lies
within a block of high linkage disequilibrium, which
contains four genes, KIAA1109, TENR, IL2 and IL21. As
for the other diseases, it is the common allele, which
predisposes to JIA. This association confirms a recently
published association of the IL2_IL2 region with JIA
susceptibility.21 We performed a meta-analysis of the two
studies, which yielded highly significant evidence for
association (odds ratio 0.77 95% confidence interval 0.69–
0.87, P¼ 1105) with no evidence for heterogeneity
between the two cohorts (P¼ 0.81). This finding is
interesting in light of the previous confirmed association
of the IL2RA gene with JIA6 and may suggest that the IL2
pathway is particularly important in JIA susceptibility.
We found a weak trend toward association of a SNP in
the IL7R gene with JIA (Table 1), in line with the previous
association of this SNP with RA, T1D14 and multiple
sclerosis15,16 the common allele of the SNP was increased
in cases compared with controls, although this did not
achieve statistical significance. However, this study was
under-powered with only 18% power to detect an effect
(Supplementary Table 2). Therefore, additional indepen-
dent studies and meta-analyses of this SNP will be
required to confirm it as associated with JIA suscept-
ibility. The SNP is a non-synonymous SNP within exon 6
of IL7R and has a functional effect on gene expression,
resulting in altered ratios of soluble and membrane-
bound isoforms of the protein.15
SNPs within the CTLA4 gene, previously associated
with T1D and autoimmune thyroid disease17 have
previously been examined in JIA with conflicting
results.22,23 This may reflect true genetic heterogeneity
at this locus or may be due to the modest sample sizes
used in previous investigations. We found a weak
association of the CTLA4 CT60 SNP (rs3087243) with
UK JIA cases (Table 1), although this study only had 53%
power to detect an effect (Supplementary Table 2).
However, no evidence for association of this SNP with
JIA was detected in a recent large study of US JIA
families and controls.23 We used the Cochran–Mantel–
Haenszel test to perform a meta-analysis combining data
from this study and the Prahalad study; this yielded
weak but statistically significant evidence for association
(odds ratio 0.92 95% confidence interval 0.84–1.0,
P¼ 0.05) with no evidence for heterogeneity (by Bre-
slow–Day test) between the two cohorts (P¼ 0.44).
Further analysis of this SNP in independent data sets
followed by meta-analysis will be essential to robustly
determine whether CTLA4 represents a JIA susceptibility
locus. It is obviously a good candidate as an autoimmune
susceptibility locus because of its role as a negative
regulator of T-cell activation.17 Furthermore, the CT60
SNP is found within the 30 untranslated region, in which
the G allele is associated with susceptibility to several
autoimmune diseases and also has a functional effect of
lower mRNA levels of the soluble CTLA4 isoform.17
Finally, a non-synonymous SNP, rs763361, in exon 7 of
the CD226 gene has recently been associated with
multiple autoimmune diseases including T1D, multipleTa
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sclerosis and possibly autoimmune thyroid disease and
RA.18 In our total JIA analysis, we found no significant
association of the SNP with JIA (Table 1). However, we
only had 24% power to detect an effect (Supplementary
Table 2).
Figure 1 shows a comparison between the association
analysis results in T1D, RA, multiple sclerosis and JIA.
For all the SNPs tested, the same allele was associated
with JIA as was associated with the other autoimmune
diseases and effect sizes are similar. Hence, the failure
to confirm association with CTLA4 and IL7R at the
corrected threshold could be due to a lack of statistical
power (53 and 18%, respectively) (Supplementary
Table 2). It has not always been the case for the
overlapping autoimmune disease susceptibility loci, that
the same allele is associated. For example in PTPN22, the
minor allele of the R620W SNP is associated with greater
risk of developing RA, JIA, T1D and SLE but is protective
for Crohn’s disease.24,25 There is also emerging data
suggesting that one of the associated SNPs at the IL2RA
locus confers differing risk and protective effects for T1D
and multiple sclerosis.26,27
JIA is a phenotypically heterogeneous disease and can
be classified into more clinically homogeneous diseases
using the ILAR classification criteria (Supplementary
Table 1).28 However, comparing each of the ILAR
subtypes separately against controls would result in a
large number of hypothesis tests. Therefore, we first
examined whether there was evidence of a difference in
allele frequencies between the seven ILAR subtypes.
Differences between subtypes were assessed using w2
tests on the 7 2 tables. Only when a difference was
found (Po0.05) were separate odds ratios and 95%
confidence intervals calculated for the subgroups. In all
cases, this was not significant (P40.05) (data not shown).
Therefore, further stratification by ILAR subtype was not
performed. Larger sample sizes will be required to fully
examine subgroup differences.
In conclusion, adopting the strategy of targeting loci
with previous evidence for association in multiple
autoimmune diseases has identified two novel JIA loci,
AFF3 and the IL2/IL21 locus.
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